EUVIMEDEUVIMED entdecken
Crossref

Precise Targeting One‐Carbon Metabolism for Potent Cancer Therapy and Metastasis Suppression

Qingping Feng, Wenting Zhang, Yinghua Peng, Chuanqi Zhao, Jinsong Ren, Xiaogang Qu iD

Small · 2025

DOI: 10.1002/smll.202504631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Qingping Feng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: Carbon, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One‐carbon (1C) metabolism supports the de novo synthesis of purines and pyrimidines, which are essential for cancer growth. So far, the most employed assay for targeting 1C metabolism is using the inhibitors of specific enzymes. However, metabolic compensation undermines their efficacy, and the lack of cell selectivity limits their application. Herein, a bifunctional Pd nanocatalyst coated with the cancer cell membrane (Pd@M) has been constructed to target 1C metabolism in cancer cells, delivering precise and potent cancer therapy. On the one hand, the Pd@M can catalyze formate and cause its depletion to disrupt cytoplasmic 1C metabolism and suppress cell metastasis. On the other hand, the Pd@M activates prodrugs in situ by bioorthogonal catalysis to inhibit the compensatory pathway, which strongly decreases nucleotide synthesis flux, thus causing potent inhibition of cell proliferation. This work presents a new way to disrupt cytoplasmic 1C metabolism and suppress cell metastasis by combination of precise depletion of cancer cell formate and inhibition of the compensatory pathway by using bioorthogonal chemistry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbonNeoplasmsHumansCell Line, TumorNeoplasm MetastasisCell ProliferationAnimalsPalladiumProdrugsMice

Stichwörter der Autor:innen

bioorthogonalcancer therapymetastasis suppressionnanocatalystsone‐carbon metabolism

Substanzen

CarbonPalladiumProdrugs

Autor:innen und Institutionen

  • Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
  • Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, Jilin, 130112, P. R. China.

ORCID-Profile: Xiaogang Qu

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Feng, Q., Zhang, W., Peng, Y., Zhao, C., Ren, J., & Qu, X. (2025). Precise Targeting One‐Carbon Metabolism for Potent Cancer Therapy and Metastasis Suppression. Small. https://doi.org/10.1002/smll.202504631

Vancouver

Feng Q, Zhang W, Peng Y, Zhao C, Ren J, Qu X. Precise Targeting One‐Carbon Metabolism for Potent Cancer Therapy and Metastasis Suppression. Small. 2025. doi:10.1002/smll.202504631

BibTeX
@article{Feng2025,
  author = {Feng, Qingping and Zhang, Wenting and Peng, Yinghua and Zhao, Chuanqi and Ren, Jinsong and Qu, Xiaogang},
  title = {Precise Targeting One‐Carbon Metabolism for Potent Cancer Therapy and Metastasis Suppression},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202504631}
}
Kostenlos starten →